Springboard Equity Inc. has launched an equity crowdfunding platform – dedicated exclusively to the healthcare industry to bring capital to vetted, high potential, early stage innovative companies. The platform aims to make the fundraising process more efficient for medical devices, digital health, biotech, health IT, mobile and diagnostics startups.
Launched in July 2015, Springboard spent the first five months building their technology, their investor community, and different affiliates. The platform launched a month in December with its first issuing company and they are currently reviewing and vetting approximately 25 additional companies that have applied to be listed on the platform.
“When you look at industry specific platforms, the value it brings is a more vested interest into that specific industry,” said Lyle Martin, CEO of Springboard Equity. “For us, looking at crowd investing specific for healthcare, our outreach and the network that we build from an investor community all has an interest in healthcare and healthcare specific companies. Thus, for an issuing company, the real value proposition is that you’re going to get a highly interested audience versus generalized opportunities or the traditional ways of going out to different accredited investors.”
According to Bloomberg, 80% of businesses don’t see their second year, let alone the companies that never see a single product sold or service provided. One of the reasons that these innovative and, potentially game-changing healthcare companies do not go forward is due to a lack of resources.
Although initial funding may have been secured, additional capital may be needed in order to maintain operations, continue research or to further product development. In short, these companies fold because funds simply run out. With Springboard Equity’s equity crowdfunding platform, investors are presented with an ideal environment to identify good opportunities with strong ROI potential.
